These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996]. Bos AB, van Ballegooijen M, van den Akker-van Marle ME, Habbema JD. Ned Tijdschr Geneeskd; 2002 Aug 24; 146(34):1586-90. PubMed ID: 12224483 [Abstract] [Full Text] [Related]
3. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer]. Jensen ML, Dybdahl H, Svanholm H. Ugeskr Laeger; 2000 May 22; 162(21):3024-7. PubMed ID: 10850190 [Abstract] [Full Text] [Related]
6. Adequacy of cellular material in split-sampling of cervical scrapings for routine cancer screening: an analysis of 702 smears. Othman N, Othman NH. Malays J Pathol; 2012 Dec 22; 34(2):115-21. PubMed ID: 23424773 [Abstract] [Full Text] [Related]
7. Overview of the cytology laboratory: specimen processing through diagnosis. Joste N. Obstet Gynecol Clin North Am; 2008 Dec 22; 35(4):549-63; viii. PubMed ID: 19061816 [Abstract] [Full Text] [Related]
8. The prevention of cervical cancer: the place of the cytological smear test. Hudson E. Clin Obstet Gynaecol; 1985 Mar 22; 12(1):33-51. PubMed ID: 3888487 [Abstract] [Full Text] [Related]
10. [Cervix cytology: Cervex Brush versus conventional cotton swab]. Altermatt HJ, Wyler K, Fravi R, Liu X, Kraft R, Dreher E. Praxis (Bern 1994); 1997 Jun 11; 86(24):1029-33. PubMed ID: 9312820 [Abstract] [Full Text] [Related]
11. [Comparison of the ThinPrep monolayer technique and conventional cervical Pap smears in a high-risk population using the Munich II nomenclature]. Lellé RJ, Cordes A, Regidor M, Maier E, Flenker H. Gynakol Geburtshilfliche Rundsch; 2007 Jun 11; 47(2):81-7. PubMed ID: 17440269 [Abstract] [Full Text] [Related]
16. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A. BJOG; 2004 Aug 11; 111(8):842-8. PubMed ID: 15270934 [Abstract] [Full Text] [Related]
18. [Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients]. Saurel J, Rabreau M, Landi M, Bondu C, Montoya G, Morancé C, Auber M, Percheron N, Santa-Maria M, Bec M, Berteau MJ, Muller E, Gominet C, Besserves S, Thomas E. Contracept Fertil Sex; 1999 Dec 11; 27(12):853-7. PubMed ID: 10676042 [Abstract] [Full Text] [Related]
19. Influence of specimen adequacy on the diagnosis of ASCUS. Sebastião AP, Noronha Ld, Pinheiro DL, Collaço LM, de Carvalho NS, Bleggi-Torres LF. Diagn Cytopathol; 2004 Sep 11; 31(3):155-8. PubMed ID: 15349983 [Abstract] [Full Text] [Related]